About CBR International
CBR International is a Healthcare company based in Haarlem (Netherlands) founded in 2001, and was acquired by Novotech in January 2023. Provider of product development, clinical strategy, and regulatory consulting services for biopharma sector. Its focus areas include Biopharma Outsourcing, Diversified and Small Molecules & Peptides.
Company details
CBR International was established in 2001 and is based in Haarlem, Netherlands. Consulting services focused on product development, clinical strategy, and regulatory affairs are delivered to clients in the biopharma sector. Operations support various stages of drug development, from early planning to market approval. Expertise is applied across international projects, with an emphasis on compliance and strategic guidance in a regulated industry.
- Headquarters Haarlem, Netherlands
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website cbrintl.com
- Social LinkedIn
- Acquired by Novotech (Jan 2023)
- Investors
- Acquired byNovotech
(Jan 2023)
Investors in CBR International
CBR International has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Novotech CRO.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Provider of clinical research services across all trial phases and therapeutic areas | 2002 | novotech-cro.com | Sydney, Australia |
Investor details for CBR International
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of CBR International
2 dated milestones of CBR International across 22 years, from founding to its latest funding, stage changes and deals.
- Founded CBR International is founded.
- Exit Acquired by Novotech.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Cbr International
Complete news archive for CBR International
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CBR International
CBR International was founded in 2001.
CBR International is headquartered in Haarlem, Netherlands. It is registered at Haarlem, Noord-holland, Netherlands.
CBR International was established in 2001 and is based in Haarlem, Netherlands. Consulting services focused on product development, clinical strategy, and regulatory affairs are delivered to clients in the biopharma sector. Operations support various stages of drug development, from early planning to market approval. Expertise is applied across international projects, with an emphasis on compliance and strategic guidance in a regulated industry.
CBR International has 1 investor. Key investors include Novotech CRO.
Yes. CBR International was acquired by Novotech in January 2023.